{
    "2018-07-23": [
        [
            {
                "time": "2018-08-15",
                "original_text": "What’s Next for Pfizer Stock After Being Called Out by President Trump",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "President Trump",
                        "called out"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-23",
                "original_text": "With new attack on Alzheimer's, this young biotech is hiring, grabbing more space",
                "features": {
                    "keywords": [
                        "Alzheimer's",
                        "biotech",
                        "hiring"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-31",
                "original_text": "Is a Beat in Store for Bristol-Myers (BMY) in Q2 Earnings?",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Q2 Earnings",
                        "beat"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-25",
                "original_text": "Healthcare ETFs to Buy on Solid Q2 Earnings Expectations",
                "features": {
                    "keywords": [
                        "Healthcare ETFs",
                        "Q2 Earnings",
                        "expectations"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-01",
                "original_text": "Better Buy: Gilead Sciences, Inc. vs. Celgene",
                "features": {
                    "keywords": [
                        "Gilead Sciences",
                        "Celgene",
                        "comparison"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-30",
                "original_text": "AbbVie's Stock Is a Bargain After Falling 8% Last Week",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "bargain",
                        "falling"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-27",
                "original_text": "How Johnson & Johnson’s Earnings Trended in Q2 2018",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "earnings",
                        "trended"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "AbbVie's Stock Is a Bargain After Falling 8% Last Week",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "bargain",
                        "falling"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}